Program
EN001
A development code.
Its studies are mostly in Charcot-Marie-Tooth Disease · Muscular Dystrophy, Duchenne · Sarcopenia, led by ENCell.
Furthest: phase 2, since Feb 19, 20245 company-led studies, 3 open or runningNext primary completion: Dec 31, 2026 (phase 2)
Who develops it
Each company that leads studies of it, as its sponsor page counts them.
| Company | Studies it leads | Furthest phase | First study | Next primary completion |
|---|---|---|---|---|
| ENCell | 53 open or running | phase 2since Feb 19, 2024 | Jan 6, 2022 | Dec 31, 2026phase 2 · NCT06328712 |
History and what’s ahead
From the studies’ own records, by the day each was first submitted. Purple marks an event: a company’s first study, a phase reached, a study stopped, a primary completion moved later (stops and moved dates are recorded from Sep 25, 2026). Dates ahead are the sponsors’ estimates.
- Jan 6, 2022First studies: 2 phase 1 studiesFirst studyNCT05338099, NCT05333406
- Feb 19, 20242 phase 2 studiesNCT06328725, NCT06328712
- Sep 2, 2026Phase 2 study in SarcopeniaNCT07808905 · 132 planned · South Korea
Ahead
- Dec 31, 2026Primary completion: phase 2 study in Charcot-Marie-Tooth DiseaseNCT06328712
- Oct 31, 2029Primary completion: phase 2 study in SarcopeniaNCT07808905
TargetBeta
Not stated by its company or a source we have read. Most early programs say nothing of it.
Studies
All 5 led by companies developing it, newest first. Each opens its study page.
| Study | Phase | Status | Primary completion | Size |
|---|---|---|---|---|
| NCT07808905Sarcopenia · South Korea | 2 | Not yet recruiting | Oct 31, 2029 | 132 |
| NCT06328725Muscular Dystrophy, Duchenne · Korea, Republic of | 2 | Not yet recruiting | Nov 2025 | 88 |
| NCT06328712Charcot-Marie-Tooth Disease · South Korea | 2 | Recruiting | Dec 31, 2026 | 27 |
| NCT05338099Muscular Dystrophy, Duchenne · Korea, Republic of | 1 | Completed | Dec 28, 2022 | 7 |
| NCT05333406Charcot-Marie-Tooth Disease · Korea, Republic of | 1 | Completed | Dec 20, 2022 | 9 |
How it is read
Names in the registry
- “EN001”, 11 entries
Codes read as this program: EN001.
Conditions, from the studies’ own filings
- Charcot-Marie-Tooth Disease, 2 studies
- Muscular Dystrophy, Duchenne, 2 studies
- Sarcopenia, 1 study
First seen by our ledger Nov 13, 2026.
What this can’t show
- Only studies on ClinicalTrials.gov. Studies only in China’s, Europe’s or other registries are missing here.
- Deals, prices and results are not in the registry. A licence or acquisition shows only with a dated source.
- Primary completion dates are the sponsors’ estimates and often move.
- A study counts here when it names this program among the drugs it tests; one that writes it only beside a placebo may be missed.